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ABSTRACT
Background: $SSUR[LPDWHO\RIWKHZRUOGSRSXODWLRQLVLQIHFWHGZLWKKHSDWLWLV&YLUXV+&93URWHLQRI
KHSDWLWLV&YLUXVPRGXODWHVDSRSWRVLVDQGVWHDWRVLVOLYHUFHOOLQMXU\DFWLYDWHVOLYHUVWHOODWHFHOOVDQGOLYHU¿EURVLV
Hepatitis C virus infection will cause injury to the hepatocytes. This injury to the hepatocyte will activate liver 
VWHOODWHFHOOV6WHOODWHFHOOVKDYHDKXJHUROHLQWKHGHYHORSPHQWRIOLYHU¿EURVLV7KHREMHFWLYHRIWKLVVWXG\LVWR
HYDOXDWHWKHGLIIHUHQFHRIDFWLYH&'OLYHUVWHOODWHFHOOVLQYDULRXVGHJUHHRI¿EURVLVDVZHOODVLWVUHODWLRQ
with aspartate transaminase (AST), alanine transaminase (ALT), and quantitative amount of hepatitis C virus 
ribonucleic acid (HCV RNA) in chronic hepatitis C.
Method: This study was a cross sectional study performed in 32 patients with chronic hepatitis C who had 
XQGHUJRQHOLYHU86*GLGQRWVXIIHUIURPKHSDWRPDKDGXQGHUJRQHOLYHUELRSV\3DUDI¿QEORFNRISDWLHQWV¶
liver tissue was further stained using haematoxylin and eosin technique to identify the metavir degree which is 
categorized into mild-moderate or severe degree. Special staining is performed to evaluate liver stellate cells 
WKDWZHUHWKHQFRXQWHGLQDYHUDJHO\LQ¿YH¿HOGVRIYLHZ
Results: ,QWKLVVWXG\ZHIRXQGVLJQL¿FDQWGLIIHUHQFHLQWKHDPRXQWRI&'VWHOODWHOLYHUFHOOVEHWZHHQ
VHYHUHDQGPLOGPRGHUDWH¿EURVLVSWKHUHZDVQRDVVRFLDWLRQEHWZHHQ&'VWHOODWHOLYHUFHOOVZLWK
AST (p = 0.2) or ALT (p = 0.7), and there was association between CD38+ stellate liver cells with quantitative 
HCV RNA (r = -0.372).
Conclusion: 7RWDODPRXQWRI&'VWHOODWHOLYHUFHOOVLQVHYHUH¿EURVLVZDVKLJKHUFRPSDUHGWRWKHWRWDO
DPRXQWRI&'OLYHUVWHOODWHFHOOVLQPLOGPRGHUDWH¿EURVLV7KHUHZDVQRDVVRFLDWLRQEHWZHHQWKHYDOXHRI
AST, ALT, and quantitative HCV RNA with the number of CD38+ stellate liver cells.
Keywords: CD38+ stellate cells, chronic hepatitis C, aspartate aminotransferase (AST), alanine 
aminotransferase (ALT), viral load hepatitis C virus ribonucleic acid (HCV RNA)
ABSTRAK
Latar belakang:6HNLWDUSRSXODVLGLGXQLDWHULQIHNVLYLUXVKHSDWLWLV&3URWHLQYLUXVKHSDWLWLV&PHPRGXODVL
DSRSWRVLVGDQVWHDWRVLVFHGHUDVHOKDWLPHQJDNWLINDQVHOVWHODWDKDWLGDQ¿EURVLVKDWL,QIHNVLYLUXVKHSDWLWLV
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C akan menimbulkan cedera pada hepatosit. Cedera pada hepatosit ini akan mengaktivasi sel stelata hati. Sel 
VWHODWDEHUSHUDQEHVDUSDGDSURVHVSHUNHPEDQJDQ¿EURVLVKDWL7XMXDQSHQHOLWLDQLQLDGDODKXQWXNPHQJHWDKXL
SHUEHGDDQ MXPODK VHO VWHODWD KDWL DNWLI&'SDGDEHUEDJDL GHUDMDW ¿EURVLV VHUWD KXEXQJDQQ\DGHQJDQ
aspartate aminotransferase (AST), alanine aminotransferase (ALT), jumlah hepatitis c virus ribonucleic acid 
(HCV RNA) kuantitatif pada hepatitis C kronik.
Metode: Penelitian ini merupakan studi potong lintang yang dilakukan pada 32 pasien hepatitis C kronik 
\DQJVXGDKGLODNXNDQXOWUDVRQRJUD¿86*KDWLGDQWLGDNPHQGHULWDKHSDWRPDVHUWDWHODKGLODNXNDQELRSVLKDWL
3DUDI¿QEORFNMDULQJDQKDWLSDVLHQVHODQMXWQ\DGLZDUQDLPHQJJXQDNDQWHNQLNKHPDWRNVLOLQHRVLQXQWXNPHQLODL
derajat metavir yang dikategorikan menjadi derajat ringan-sedang atau berat. Pewarnaan khusus dilakukan 
untuk menilai sel stelata hati yang dihitung rata-rata pada lima lapangan pandang.
Hasil: Pada penelitian ini didapatkan perbedaan jumlah sel stelata hati CD38+ yang bermakna antara 
¿EURVLVGHUDMDWEHUDWGDQGHUDMDWULQJDQVHGDQJSWLGDNGLGDSDWNDQKXEXQJDQDQWDUDVHOVWHODWDKDWL
CD38+ dengan AST (p = 0,2) maupun ALT (p = 0,7), dan tidak didapatkan hubungan antara sel stelata hati 
CD38+ dengan HCV RNA kuantitatif (r = -0,372).
Simpulan: -XPODKVHOVWHODWDKDWL&'SDGD¿EURVLVEHUDWOHELKWLQJJLGDULSDGDMXPODKVHOVWHODWDKDWL
&'SDGD¿EURVLVULQJDQVHGDQJ7LGDNWHUGDSDWKXEXQJDQDQWDUDQLODL$67$/7GDQ+&951$NXDQWLWDWLI
dengan jumlah sel stelata hati CD38+.
Kata kunci: CD38+ sel stelata, hepatitis C kronik, aspartate aminotransferase (AST), alanine aminotransferase 
(ALT), viral load hepatitis c virus ribonucleic acid (HCV RNA)
INTRODUCTION
Approximately 3% of the world population is 
infected with hepatitis C virus. Protein of the hepatitis 
C virus modulates apoptosis and steatosis, liver cell 
LQMXU\DFWLYDWHVOLYHUVWHOODWHFHOOVDQGOLYHU¿EURVLV
Around 10-20% will develop into liver cirrhosis and 
hepatocellular carcinoma. While the body immune 
system tries to eliminate the virus, liver cells injury 
DQG¿EURVLVLQFKURQLFLQIHFWLRQKDSSHQWKURXJKGLUHFW
FHOOXODUWR[LFLW\DQGUHOHDVHRIORQJWHUPLQÀDPPDWRU\
cytokines.1,2 Hepatitis C virus infection will cause 
injury to the hepatocytes. This injury to the hepatocytes 
will activate liver stellate cells. Activated stellate cells 
FKDQJHV LQWRFHOOVVXFKDVP\R¿EUREODVWZKLFKZLOO
WKHQVWDUWWKH¿EURJHQHVLVSURFHVV/LYHU¿EURVLVLVD
reaction of granulation tissue development which is 
associated with injury to the liver parenchyma cells 
and occurs in the long-term. Fibrogenic response is 
marked by the accumulation of extracellular matrix 
WKDW LV KLJK LQ FROODJHQ¿EUH DQG IDLOXUH RIPDWUL[
WXUQRYHUSURFHVV5HJUHVVLRQRI¿EURVLVSURFHVVFDQ
be achieved by ceasing the chronic injury process 
towards the liver cells. By ceasing the injury to liver 
FHOOVOLYHUP\R¿EUREODVWZLOOGLVDSSHDU3 Although it 
has been known that other mesenchymal liver cells also 
contribute in the accumulation of extracellular matrix, 
stellate cells activation pathway is still considered as the 
PDLQSDWKZD\LQWKHSURFHVVRIOLYHU¿EURVLVWKURXJKLWV
response towards liver tissue injury.4 These cells have 
KXJHUROHLQWKHGHYHORSPHQWRIOLYHU¿EURVLVWKXVWKH
effort to the identify active stellate cells is an important 
thing in the process of understanding pathogenesis, 
WKHUDS\DQGOLYHU¿EURVLVHYDOXDWLRQ5
Stellate liver cell itself is a mesenchymal cell in 
the liver that has high degree of heterogenicity and 
plasticity; therefore it contains many compounds 
WKDW FDQ EH XVHG IRU LGHQWL¿FDWLRQ SDUWLFXODUO\ E\
immunohistochemical staining. One of the potential 
immunohistochemical marker is CD38+, this is a cell 
membrane molecule of the active liver stellate cells 
which has been known to be expressed in rats’ liver 
stellate cells in vitro and in vivo.4-7 A study performed 
by Abdeen et al in chronic hepatitis patients revealed 
that CD38+ staining could be used to identify liver 
stellate cells and was a strong predictor for moderate 
DQGVHYHUHGHJUHHRI¿EURVLV$VWXG\E\(O*HQGLHW
al in chronic hepatitis C patients proved that CD38+ 
liver stellate cells count was strongly correlated with 
0(7$9,5DFWLYLW\DQG¿EURVLVVFRUH8
In identifying METAVIR fibrosis score from 
mild to severe, CD38+ staining technique has better 
VSHFL¿FLW\FRPSDUHGWRĮ60$ZKLFKLVYV. 
77.27% with lower sensitivity, which was 90% vs. 
95%. Additionally, the positive predictive value of 
&'LVZKLOHĮ60$LV7KHQXPEHU
of chronic hepatitis C (CHC) virus affects the injury 
in hepatocytes. This number of CHC virus is measured 
in the form of quantitative HCV RNA. Hepatocyte 
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cell which is injured will release transaminase enzyme 
in the form of aspartate aminotransferase (AST) and 
alanine aminotransferase glutamic (ALT) which can be 
measured in the blood.4 According to Sandulescu et al, 
there was weak association between ALT and active 
liver stellate cells in chronic hepatitis C.9,10 In the last 
few years, studies using CD38+ as a liver stellate cells 
marker was still rarely performed. This study aimed to 
identify the association between CD38+ liver stellate 
cells count and several clinical parameters in CHC 
SDWLHQWVLQFOXGLQJGHJUHHRI¿EURVLVTXDQWLWDWLYH+&9
RNA, AST and ALT values.
METHOD
This study was an observational analytic study and 
used cross sectional study design. Research would 
be performed in Cipto Mangunkusumo Hospital by 
analysing medical records. Target population in this 
study was chronic hepatitis C patients. Inclusion criteria 
in this study were chronic hepatitis C patients who had 
undergone biopsy, patient gave consent to participate in 
the study. Exclusion criteria of this study were presence 
of hepatocellular carcinoma in patients, hepatoprotector 
drugs consumption, viral infection which could increase 
AST-ALT, diabetes mellitus, fatty liver, not currently 
suffering from typhoid fever; not currently suffering 
from pulmonary tuberculosis. All samples included 
in this study would receive explanation before hand 
on the objectives, procedures to be performed, and 
complications that might happen in this study. Samples 
could only participate if they had given written consent. 
Variables that would be evaluated were number of 
&'OLYHUVWHOODWHFHOOVGHJUHHRI¿EURVLV$67YDOXH
ALT value, and quantitative HCV RNA.
Samples are study subjects who are part of the 
DFFHVVLEOHSRSXODWLRQDQGKDYHIXO¿OOHGWKHLQFOXVLRQ
and exclusion criteria. Study samples were collected 
by identifying data of chronic hepatitis C patients 
who had undergone liver ultrasonography (USG), did 
not suffer from hepatoma, and had undergone liver 
ELRSV\)XUWKHUSDUDI¿QEORFNRIWKHVHSDWLHQWVZHUH
searched in the Pathological Anatomy Department, 
Faculty of Medicine, University of Indonesia (FMUI)/
Cipto Mangunkusumo Hospital, and later the Metavir 
GHJUHHLQWKHVHVDPSOHVZHUHLGHQWL¿HG5HVXOWVZHUH
categorized into mild or severe degree, and were further 
JLYHQVSHFL¿FVWDLQLQJIRUOLYHUVWHOODWHFHOOV)URPWKH
results of this staining, number of stellate liver cells 
ZRXOGEHFRXQWHGLQ¿HOGVRIYLHZDQGDYHUDJHZRXOG
be counted.
Data collected from this study was number of 
OLYHUVWHOODWHFHOOVPHWDYLUGHJUHHIURPSDUDI¿QEORFN
of liver biopsy, AST, ALT values; quantitative HCV 
51$,QVWUXPHQWEHLQJXVHGLQWKLVVWXG\ZDVSDUDI¿Q
block of the liver biopsy with the following steps: to all 
SDUDI¿QEORFNVWDNHQIRUVWXG\VXEMHFWVXQVWDLQHGVOLGH
cutting would be performed for immunohistochemical 
staining with 4 micron thickness using avidin biotin 
PHWKRGVSDUDI¿QEORFNVZKLFKDUHUHDG\ZHUHIXUWKHU
HYDOXDWHGIRUGHJUHHRILQÀDPPDWLRQDQG¿EURVLVODWHU
for immunohistochemical staining of liver stellate 
cells, CD38+ was used. From these staining, we could 
FRXQWWKHDPRXQWRIOLYHUVWHOODWHFHOOVSHU¿HOGRIYLHZ
¿HOGVRIYLHZODWHUZHFRXQWHGWKHDYHUDJHDPRXQW
and presented the results in numerical category.
Obtained research results would be analysed 
statistically to evaluate the correlation between 
independent and dependent variables. Data from the 
research results was further recorded and analysed 
using SPSS version 13. Data would be presented in 
WKHIRUPRIWDEOHVDQG¿JXUHV3 Hypothesis testing was 
performed by bivariate analysis between independent 
variables and each dependent variables in numeric-
FDWHJRULFDOPHDVXUHPHQWVFDOHIRUGHJUHHRI¿EURVLV
variables and numeric for AST, ALT, and quantitate 
HCV RNA variables. For data in numeric-numeric 
measurement scale, hypothesis testing being used was 
correlation test, particularly Pearson correlation test 
and Spearman correlation test. For data in numeric-
categorical measurement scale, we performed analysis 
using Mann Whitney test. Ethical clearance for this 
study has been submitted and approved by Health 
Research Ethics Committee FMUI.
RESULTS
A total of 32 biopsy preparations of chronic hepatitis 
C patients, which consisted of 20 males and 12 females 
were included in this study. Patients aged more than 
40 years old were 16 patients and those aged below 40 
were 16 patients. Table 1 showed the distribution of 
subjects’ characteristics based on sex and age. 
Table 1. Distribution of subjects’ characteristics 
based on sex and age (n=32)
Characteristics n (%)
Sex
Male 20 (62.5)
Female 12 (37.5)
Age
< 40 years old 16 (50)
\HDUVROG 16 (50)
'HJUHHRI¿EURVLV
Mild-moderate 16 (50)
Severe 16 (50)
Volume 16, Number 2, August 2015 89
CD38+ Liver Stellate Cells in Chronic Hepatitis C Patients with Fibrosis 
,QWKLVVWXG\WKHUHZDVVLJQL¿FDQWGLIIHUHQFHLQWKH
number of CD38+ stellate liver cells between severe 
DQGPLOGPRGHUDWHGHJUHHRI¿EURVLVSDV
shown in table 2.
Table 2. Difference in the number of CD38+ stellate liver cells 
EDVHGRQWKHGHJUHHRI¿EURVLV
Variable Fibrosis P value*Severe Mild
Number of CD38+ Stellate 
Liver Cells
5.3 (3.4-7.8) 1.2 (1.0-1.6) < 0.001
*Mann Whitney Test
In this study, we reported no correlation found 
between CD38+ stellate liver cells with AST (p = 0.2) 
or even ALT (p = 0.7) value.
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Figure 1. Correlation between CD38+ liver stellate cells and 
AST value
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Figure 2. Correlation between CD38+ liver stellate cells and 
ALT value 
Analysis results on the correlation of CD38+ liver 
stellate cells and quantitate HCV RNA reported that 
there was no correlation between CD38+ liver stellate 
cells and quantitative HCV RNA (r = -0.372).
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Figure 3. Correlation between CD38+ stellate liver cells and 
quantitative HCV RNA 
DISCUSSION
In this study, we obtained higher number of CD38+ 
OLYHUVWHOODWHFHOOVLQVHYHUH¿EURVLVFRPSDUHGWRPLOG
PRGHUDWH ¿EURVLV7KH DYHUDJH QXPEHU RI&'
OLYHUVWHOODWHFHOOVLQFUHDVHGVLJQL¿FDQWO\S
LQDFFRUGDQFHZLWKWKHVHYHULW\GHJUHHRI¿EURVLVIURP
PLOGPRGHUDWH¿EURVLVZLWKQXPEHURIVWHOODWHFHOOVRI
±WRVHYHUH¿EURVLVZLWKQXPEHURIVWHOODWH
cells of 5.3 (3.4–7.8). Increase of CD38+ liver stellate 
FHOOVLQDGYDQFLQJGHJUHHRI¿EURVLVZDVDOVRLQOLQH
with the results of previous study by El-Gendi et al.7 
7KHVWXG\DLPHG WRFRQ¿UP&'H[DPLQDWLRQDV
an immunohistochemistry marker ro detect stellate 
cells and evaluate the correlation between number 
RI&' DQG ¿EURVLV VFRUH DQG VHPLTXDQWLWDWLYH
assessment method towards activated stellate cells 
IURP OLYHUELRSV\DQGXVLQJ&'DQGĮ60$
immunostaning. Similar results were also found in 
the study performed by Abdeen et al.8 The objectives 
of this study were similar to the study by El-Gendi et 
al. However, more samples were included compared 
to the study by El-Gendi et al. In the study conducted 
by Abdeen et al, 100 liver biopsies of chronic liver 
disease patients were studied. The results of this study 
also revealed the increase of CD38+ liver stellate 
cells in accordance with the advancing degree of 
¿EURVLVIURPPLOGWRVHYHUH7KLVZDVFRQVLVWHQWZLWK
the hypothesis that CD38+ liver stellate cells would 
increase in concordance with the advancing degree of 
¿EURVLVRIWKHOLYHUFHOOV$UHWURVSHFWLYHVWXG\ZKLFK
was conducted by Tomanovic et al, studied 20 liver 
biopsy samples of chronic hepatitis C patients and 10 
normal liver biopsy samples. Results showed that there 
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ZDVSRVLWLYH FRUUHODWLRQ EHWZHHQGHJUHH RI¿EURVLV
with the number of active liver stellate cells.1 In that 
study, it was concluded that activated liver stellate cells 
FRXOGEHDSURJQRVWLFPDUNHUIRUVHYHUH¿EURVLVDQG
liver cirrhosis in chronic hepatitis C patients.
Results of correlation analysis between CD38+ liver 
stellate cells and AST in chronic hepatitis C patients in 
this study showed that there was no correlation between 
AST and number of CD38+ liver stellate cells in 
chronic hepatitis C patients (p = 0.20). Study conducted 
by Nadeem et al in 107 non-cirrhotic hepatitis C 
patients and had not received treatment for hepatitis 
C revealed that there was no association between AST 
YDOXH DQG GHJUHH RI OLYHU ¿EURVLVZKLFK LPSOLFLWO\
showed that there was no correlation between AST 
value and number of CD38+ liver stellate cells.11 This 
FRXOGEH FDXVHGE\$67ZKLFK LV QRWRQO\ VSHFL¿F
to represent condition of the liver but also that of the 
heart, skeletal muscle, kidney, brain, and red blood 
cells.12 Meanwhile, for correlation analysis between 
CD38+ liver stellate cells and ALT in chronic hepatitis 
C patients that hepatocellular injury could lead to the 
release of cytosol alanine transaminase enzyme into 
the blood circulation. ALT value is often used as a 
marker of liver injury in chronic hepatitis C patients, 
which include assessment to progressivity, evaluation 
of therapy and prognosis.13 In this study, the obtained 
results showed that there was no correlation between 
ALT and number of CD38+ liver stellate cells in 
chronic hepatitis C patients (p = 0.70). Study performed 
by Pradat et al to 864 positive HCV RNA patients with 
normal ALT value for 6 months which was measured 
from the time of liver tissue collection to ALT value 
before administration of therapy.14 Normal ALT value 
ZDV GH¿QHG DV YDOXH OHVV WKDQ XSSHU QRUPDO OLPLW
ZKLOHSHUVLVWHQWQRUPDO$/7ZDVGH¿QHGDVFRQWLQXRXV
normal value which was obtained for 6 months. The 
study revealed that there was no correlation between 
GHJUHHRIOLYHU¿EURVLVDQG$/7LQFKURQLFKHSDWLWLV
C patients before receiving therapy. This could be 
caused by the activity of ALT which changes easily, 
ÀXFWXDWLYHDQG LQÀXHQFHGE\RWKHU IDFWRUV VXFKDV
sex, body mass index. In chronic hepatitis C patients, 
liver cell death can occur through apoptosis and 
necrosis, thus the cells that are almost dead produce 
less ALT. This explains why there was weak correlation 
EHWZHHQLQFUHDVHRI$/7DQGGHJUHHRIOLYHU¿EURVLV13 
Puoti et al also studied 46 carrier hepatitis C patients 
with persistent normal ALT and compared them with 
52 positive HCV RNA patients with increased ALT 
value.15 Results of this study revealed that there was 
no difference between patients with normal ALT value 
and patients with increased ALT value, therefore it was 
concluded that there was no correlation between the 
GHJUHHRIOLYHU¿EURVLVDQG$/7YDOXHV7KXVE\WKH
DEVHQFHRIFRUUHODWLRQEHWZHHQGHJUHHRIOLYHU¿EURVLV
and ALT value, indirectly it showed that there was no 
correlation between CD38+ liver stellate cells and ALT 
value. Number of publications which opposed this 
assertion encouraged Kyrlagkitsis et al to conduct a 
retrospective study to 91 chronic hepatitis C patients 
with persistent normal ALT value and to 94 patients 
with abnormal liver biochemistry by comparing liver 
histology appearance from each groups.16 Development 
RI¿EURVLVZDVDVVHVVHGDVHDUO\DVWKHWLPHRILQIHFWLRQ
Researchers reported one from six chronic hepatitis C 
SDWLHQWVZLWKSHUVLVWHQWQRUPDO$/7YDOXHVLJQL¿FDQWO\
experienced progressive liver disease. They also found 
OHVVHUGHJUHHRI¿EURVLVLQSDWLHQWVZLWKQRUPDO$/7
compared to patients with abnormal ALT value.13
Assessment of correlation between quantitative 
HCV RNA and CD38+ liver stellate cells in chronic 
hepatitis C patients showed that there was no 
correlation between quantitative HCV RNA and 
CD38+ liver stellate cells. This was similar with the 
cohort study conducted by Fanning et al to 77 chronic 
hepatitis C patients by monitoring clinical parameter, 
biochemistry, and histology.17 The results of the study 
revealed that there was no significant correlation 
between quantitative HCV RNA with degree of liver 
¿EURVLV17 Study performed by Romeo et al also reported 
similar result. The study was conducted to 170 chronic 
hepatitis C patients and 27 hepatocellular carcinoma 
patients who had undergone liver biopsy. The results 
of the study exhibited that advancement of hepatitis C 
disease was not associated with genotype difference 
or HCV RNA level.18 Deterioration of hepatitis C 
disease was in accordance with the development of 
OLYHU ¿EURVLVZKLFKZDV DOVR LQ FRQMXQFWLRQZLWK
the increase of liver stellate cells. Hence, we could 
conclude that HCV RNA level was not correlated with 
liver stellate cells.
CONCLUSION
From this study, we can conclude that the number of 
&'VWHOODWHOLYHUFHOOVLQVHYHUH¿EURVLVZDVKLJKHU
compared to the number of CD38+ stellate liver cells in 
PLOGPRGHUDWH¿EURVLV7KHFRUUHODWLRQEHWZHHQ$67
and number of CD38+ stellate liver cells; between 
ALT and number of CD38+ stellate liver cells and 
between quantitate HCV RNA and number of CD38+ 
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stellate liver cells were not found. Therefore, further 
studies are needed to develop soluble CD38+ from 
WKHEORRG VHUXPDVELRPDUNHU LQ OLYHU¿EURVLV UROH
of active CD38+ stellate cells in chronic hepatitis C 
with normal ALT value and further studies are needed 
to identify the association between quantitative HCV 
RNA with other cells, to prevent the development of 
liver cirrhosis.
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